Clinical Trials on Teriflunomide
Total 2 results
-
Derrick Scott RobertsonUniversity of South Florida; Genzyme, a Sanofi CompanyTerminatedHealthy Volunteers | Teriflunomide EliminationUnited States
-
University at BuffaloCompleted
Sponsors and Collaborators
- Genuv Inc.
- FutureGen Biopharmaceutical (Beijing) Co., Ltd
- Sahar Salehi
- Liming Cheng
- Hoersholm Hospital
- Pancreatic Cancer UK
- Kuwait University
- Klinikum Bad Woerishofen
- Xiao-Ming Mao
- The People's Hospital of Guangxi Zhang Autonomous Region
- Friedrich Miescher Institute for Biomedical Research (FMI)
- Kerstyn C. Zalesin, M.D.
- Egyptian Russian University
- Jia Liu
- Marcus Vinícius Guimarães de Lacerda
- Only For Children Pharmaceuticals
- Van Boven, Robert W., M.D.
- Hopeful Aging
- Biorobotic Institute Scuola Superiore sant'Anna Pisa
- Royal Hobart Hospital Research Foundation (funding source)
- View Full List
Medical Conditions
- Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia
- Global Health
- Autologous Haematopoietic Stem Cell Transplant
- Secondary Hypertension to Endocrine Disorders
- Role of Vitamin D in IVF for Better Outcome
- Gait Variability; Elders; Fall; Re-education
- Raynaud Secondary to Other Autoimmune Disease
- High Perinatal Mortality
- Caffeine Dosage
- EHMT1
- Advanced Gastric Cancer With Serosal Invasion
- Enlarged Uterus
- Stage II Vulvar Cancer
- Pancytopenia Due to Chemotherapy
- Airway Obstruction
- Stereotype-threat
- Pulmonary Invasive Aspergillosis
- Using Imagery to Maintain Muscle Mass Gains in the Quadriceps
- Smith-Lemli-Opitz Syndrome
- Urinary Tract Carcinoma
- View Full List
Drug Interventions
- Oxycodone, fentanyl
- Epimedium Prenylflavonoids Extract
- Enzalutamide, Abiraterone
- Bortezomib/dexamethasone
- Lamivudine
- Insulin
- Atezolizumab
- Methotrexate
- Mupirocin Calcium
- Flibanserin 100 mg dose every evening
- PF-00868554
- Indoximod
- Cytarabine ARA-C
- SERETIDE Diskus
- Topotecan
- CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
- Polyethylene glycol 3350
- HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
- Ruxolitinib
- Cetrorelix 78 mg + 78 mg
- View Full List
CROs by country
- Contract Research Organizations in Bangladesh
- Contract Research Organizations in Belarus
- Contract Research Organizations in Dominican Republic
- Contract Research Organizations in Ireland
- Contract Research Organizations in Lithuania
- Contract Research Organizations in Malaysia
- Contract Research Organizations in Mongolia
- Contract Research Organizations in Papua New Guinea
- Contract Research Organizations in Paraguay
- Contract Research Organizations in Suriname
- Contract Research Organizations in United Arab Emirates
- Contract Research Organizations in United Kingdom
- Contract Research Organizations in Zimbabwe
- CRO list by country